Biogen Idec Profit Rises 12%

Biogen Idec Inc. said its first-quarter profit jumped 12%, as strong sales of its pill-based multiple-sclerosis treatment Tecfidera drove revenue higher.



from WSJ.com: US Business http://ift.tt/1ieScWv

via IFTTT